deltatrials
Completed PHASE4 NCT01248338

Effects of Nebivolol Versus Metoprolol Succinate on Endothelial Function

Comparison the Effects of Nebivolol Versus Metoprolol Succinate on Endothelial Function and Large Artery Stiffness

Sponsor: Berlin-Chemie AG Menarini Group

Conditions Hypertension
Interventions Nebivolol metoprolol succinate
Updated 5 times since 2017 Last updated: Nov 24, 2010 Started: Mar 31, 2006 Primary completion: Dec 31, 2008 Completion: Dec 31, 2009

Listed as NCT01248338, this PHASE4 trial focuses on Hypertension and remains completed. Sponsored by Berlin-Chemie AG Menarini Group, it has been updated 5 times since 2006, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Berlin-Chemie AG Menarini Group
Data source: Berlin-Chemie AG Menarini Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Tartu, Estonia